Reimer RJ, Soper B, Wilson JL, Goncalves AR, Cadena J, Suarez P, Gryshuk AL, Osborne TF, Grimes KV, Ray P
Overview
Amy joined the University of California, San Francisco, as the Associate Director of the Office of Strategic Alliances for the department of Innovation Ventures in July 2022. She received her PhD in Molecular Pharmacology from the State University of New York at Buffalo – Roswell Park Cancer Institute. She has experience in designing, implementing, and maintaining tailored action plans and partnering strategies for multidisciplinary research collaborations and agreements with government, industry, academia, and philanthropy partners.
Previously, Amy served as a Lead within the Strategic Science Engagements Office for the Physical and Life Sciences Directorate at Lawrence Livermore National Laboratory where she coordinated high-level efforts across various Department of Energy (DOE) labs and the National Cancer Institute and was recognized in 2017 by the United States Department of Energy for the Secretary’s Appreciation Award for responding to the Vice President's Cancer Moonshot. She has focused on the application of computational predictive biology in oncology, drug discovery, and neurodegenerative efforts resulting in numerous publications and external funding.
Publications
An electronic health record cohort of Veterans with amyotrophic lateral sclerosis.
Reimer RJ, Goncalves A, Soper B, Cadena J, Wilson JL, Gryshuk AL, Suarez P, Osborne TF, Grimes KV, Ray P
Amyotrophic lateral sclerosis & frontotemporal degeneration, 2023
Kwon DH, Cadena J, Nguyen S, Chan KHR, Soper B, Gryshuk AL, Hong JC, Ray P, Huang FW
Cancer medicine, 2022
Digital twins for predictive oncology will be a paradigm shift for precision cancer care.
Hernandez-Boussard T, Macklin P, Greenspan EJ, Gryshuk AL, Stahlberg E, Syeda-Mahmood T, Shmulevich I
Nature medicine, 2021
AI Meets Exascale Computing: Advancing Cancer Research With Large-Scale High Performance Computing.
Bhattacharya T, Brettin T, Doroshow JH, Evrard YA, Greenspan EJ, Gryshuk AL, Hoang TT, Lauzon CBV, Nissley D, Penberthy L, Stahlberg E, Stevens R, Streitz F, Tourassi G, Xia F, Zaki G
Frontiers in oncology, 2019
Investigating drug induced changes in single, living lymphocytes based on Raman micro-spectroscopy.
Schie IW, Alber L, Gryshuk AL, Chan JW
The Analyst, 2014
Emerging topics and new developments in the field: the 2012 International Breath Analysis meeting.
Davis CE, Epton M, Frank M, Gryshuk A, Kenyon NJ
Cell-phone-based platform for biomedical device development and education applications.
Smith ZJ, Chu K, Espenson AR, Rahimzadeh M, Gryshuk A, Molinaro M, Dwyre DM, Lane S, Matthews D, Wachsmann-Hogiu S
PloS one, 2011
Gryshuk A, Chen Y, Goswami LN, Pandey S, Missert JR, Ohulchanskyy T, Potter W, Prasad PN, Oseroff A, Pandey RK
Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
Pandey RK, Goswami LN, Chen Y, Gryshuk A, Missert JR, Oseroff A, Dougherty TJ
Gryshuk AL, Chen Y, Potter W, Ohulchansky T, Oseroff A, Pandey RK
Pandey SK, Gryshuk AL, Sajjad M, Zheng X, Chen Y, Abouzeid MM, Morgan J, Charamisinau I, Nabi HA, Oseroff A, Pandey RK
A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy.
Chen Y, Gryshuk A, Achilefu S, Ohulchansky T, Potter W, Zhong T, Morgan J, Chance B, Prasad PN, Henderson BW, Oseroff A, Pandey RK
Bioconjugate chemistry, 2005
Chen Y, Zheng X, Dobhal MP, Gryshuk A, Morgan J, Dougherty TJ, Oseroff A, Pandey RK
Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides.
Chen Y, Sumlin A, Morgan J, Gryshuk A, Oseroff A, Henderson BW, Dougherty TJ, Pandey RK
Dobhal MP, Li G, Gryshuk A, Graham A, Bhatanager AK, Khaja SD, Joshi YC, Sharma MC, Oseroff A, Pandey RK
Li G, Pandey SK, Graham A, Dobhal MP, Mehta R, Chen Y, Gryshuk A, Rittenhouse-Olson K, Oseroff A, Pandey RK
Gryshuk AL, Graham A, Pandey SK, Potter WR, Missert JR, Oseroff A, Dougherty TJ, Pandey RK